Estimates of the prevalence of Parkinson's disease in North America have varied widely and many estimates are based on small numbers of cases and from small regional subpopulations. We sought to estimate the prevalence of Parkinson's disease in North America by combining data from a multi-study sampling strategy in diverse geographic regions and/or data sources.…
npj Parkinson's Disease Template
Write in a clean editor, then format for npj Parkinson's Disease in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the npj Parkinson's Disease format
npj Parkinson's Disease is a peer-reviewed journal published by Springer Nature, covering Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling. Over its lifetime it has published 1,476 papers, which have received 36,307 citations.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. npj Parkinson's Disease 12, 45–58 (2023).
Formats any DOI in npj Parkinson's Disease style. No sign-up. |
| Publishes research in | Parkinson's Disease Mechanisms and Treatments Neurological disorders and treatments Nuclear Receptors and Signaling Genetic Neurodegenerative Diseases Alzheimer's disease research and treatments |
| ISSN | 2373-8057 |
| Citation impact (2-yr) | 7.17 |
| h-index | 86 |
| i10-index | 770 |
| Article processing charge | $2,990 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | University College London |
| Journal website | nature.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in npj Parkinson's Disease per year
Citation impact of npj Parkinson's Disease by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in npj Parkinson's Disease
Abstract Parkinson’s disease (PD) is one of the world’s fastest growing neurological disorders. Much is unknown about PD-associated economic burdens in the United States (U.S.) and other high-income nations. This study provides a comprehensive analysis of the economic burdens of PD in the U.S. (2017) and projections for the next two decades. Multiple data sources…
The state of the intestinal environment can have profound effects on the activity of the central nervous system through the physiological contributions of the microbiota, regulation of intestinal barrier function, and altered activity of peripheral neurons. The common language employed for much of the gut-brain communication is the modulation of immune activity. Chronic proinflammatory immune…
Abstract Modeling Parkinson’s disease (PD) using advanced experimental in vitro models is a powerful tool to study disease mechanisms and to elucidate unexplored aspects of this neurodegenerative disorder. Here, we demonstrate that three-dimensional (3D) differentiation of expandable midbrain floor plate neural progenitor cells (mfNPCs) leads to organoids that resemble key features of the human midbrain.…
Parkinson disease (PD) is the second most common age-related neurodegenerative condition diagnosed in North America. We recently demonstrated, using multiple epidemiological data sources, that the prevalence of PD diagnoses was greater than previously reported and currently used for clinical, research, and policy decision-making. Prior PD incidence estimates have varied, for unclear reasons. There is a…